Chapter 130 - Renovascular and aortic developmental disorders Flashcards
Mid aortic syndrome first used by
1963 Sen
Classification of mid aortic syndrome and its relative prevalence
Suprarenal 69%
Intrarenal 23%
Infrarenal 8%
Diffuse hypoplasia of abdominal aorta - also along spectrum of disease
Embryology in mid aortic syndrome
evidence in this theory
Two dorsal aorta over-fuse
1) single lumbar instead of paired
2) multiple renal accessory arteries (2x likelihood)
Genetic syndromes associated with mid aortic syndrome
1) Neurofibromatosis NF-1 (13-25%)
2) William syndrome
3) Alagille syndrome
4) Tuberous sclerosis
Inflammatory/infectious etiology of mid aortic syndrome
1) maternal rubella in 1st trimester
2) takayasu aortoarteritis
3) umbilical artery catheterization (also associated with aortic thrombosis and mycotic aneurysms)
Aortic coarctation association with splanchnic and renal artery stenosis
Splanchnic 87%
Renal 62%
Etiology of pediatric renal artery stenosis in NA and Asia/Africa/SA
NA: developmental (NF-1)
Asia/Africa/SA: inflammatory, Takayasu
Embryologic origin of CA and SMA
Vitelline arteries
Rate of renovascular HTN as a cause of 2ndary HTN in kids
8-10%
Intetinal ischemia due to mid aortic syndrome
6% of mid-aortic syndrome patients only
Symptoms of pediatric renovascular HTN
1) HTN
2) headache, seizure, visual disturbance
3) epistaxis
4) renal insufficiency
5) Bell’s palsy
6) hemorrhagic stroke
7) hypertensive encephalopathy
8) flash pulmonary edema
Renal US to detect aortorenal stenosis sen and spe
90% sen
68% spe
Rate of cerebral vascular abnormalities in mid aortic syndrome
3-13%
occlusive and aneurysmal
Goal of HTN therapy in children
Reduce to 95percentile
If LVH or target organ identified then reduce to 90th percentile
Classes of antihypertensives
1) ACEi
2) ARBs
3) combined alpha beta blocker
4) beta blocker
5) diuretic
6) central alpha agonist
7) calcium channel blocker
8) peripheral alpha antagonist
9) vasodilators